Showing 221 - 240 results of 296 for search '"Red Cross"', query time: 0.07s Refine Results
  1. 221

    Effectiveness of Four-Decontamination Techniques on Bacterial Growth on CPR Manikins after Use in a CPR Course

    Published 2017-08-01
    “…The American Red Cross and American Heart Association are strong advocates of preventing disease transmission during cardiopulmonary resuscitation (CPR) training by promoting careful and consistent manikin decontamination. …”
    Get full text
    Article
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228

    A Convolutional Neural Network Using Anterior Segment Photos for Infectious Keratitis Identification by Satitpitakul V, Puangsricharern A, Yuktiratna S, Jaisarn Y, Sangsao K, Puangsricharern V, Kasetsuwan N, Reinprayoon U, Kittipibul T

    Published 2025-01-01
    “…Vannarut Satitpitakul,1,2 Apiwit Puangsricharern,3 Surachet Yuktiratna,3 Yossapon Jaisarn,4 Keeratika Sangsao,4 Vilavun Puangsricharern,1,2 Ngamjit Kasetsuwan,1,2 Usanee Reinprayoon,1,2 Thanachaporn Kittipibul1,2 1Center of Excellence for Cornea and Stem Cell Transplantation, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 2Excellence Center for Cornea and Stem Cell Transplantation, Department of Ophthalmology, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; 3IM Impower Company Limited, Bangkok, Thailand; 4Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandCorrespondence: Vannarut Satitpitakul, Department of Ophthalmology, King Chulalongkorn Memorial Hospital, 1873 Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand, Tel +66-894959022, Email Vannarut.S@chula.ac.thPurpose: To develop a comprehensively deep learning algorithm to differentiate between bacterial keratitis, fungal keratitis, non-infectious corneal lesions, and normal corneas.Methods: This retrospective study collected slit-lamp photos of patients with bacterial keratitis, fungal keratitis, non-infectious corneal lesions, and normal cornea. …”
    Get full text
    Article
  9. 229
  10. 230
  11. 231
  12. 232
  13. 233

    Availability, pricing, and affordability of antithrombotic medicines in Addis Ababa, Ethiopia: implications for health policy by Selam Birhanu, Melaku Tileku Tamiru, Hanan Muzeyin Kedir, Tamrat Assefa Tadesse

    Published 2025-01-01
    “…Five public hospital outpatient pharmacies, four private hospitals, ten private pharmacies, four Kenema pharmacies, and two Red Cross pharmacies in Addis Ababa, Ethiopia, were included in the study. …”
    Get full text
    Article
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238
  19. 239

    Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study by Mizoguchi Y, Hino M, Ueda H, Miyaguchi Y, Kobayashi M

    Published 2025-01-01
    “…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
    Get full text
    Article
  20. 240